Physician – Internal Medicine, Medical Oncology, Gastrointestinal Oncology (Open Rank/Track Faculty)

Screen reader users may encounter difficulty with this site. For assistance with applying, please contact hr-accessibleapplication@osu.edu. If you have questions while submitting an application, please review these frequently asked questions.

Current Employees and Students:

If you are currently employed or enrolled as a student at The Ohio State University, please log in to Workday to use the internal application process.

Welcome to The Ohio State University's career site.  We invite you to apply to positions of interest. In order to ensure your application is complete, you must complete the following:

• Ensure you have all necessary documents available when starting the application process. You can review the additional job description section on postings for documents that may be required.

• Prior to submitting your application, please review and update (if necessary) the information in your candidate profile as it will transfer to your application. 

Job Title:

Physician – Internal Medicine, Medical Oncology, Gastrointestinal Oncology (Open Rank/Track Faculty)

Department:

The Ohio State University College of Medicine and the Wexner Medical Center seek Gastroenterology (GI) Oncologist to join the Department of Internal Medicine, Division of Medical Oncology. Academic rank and track commensurate with academic record and experience.

Position Overview

Physician specializing in Gastrointestinal (GI) Oncology to serve as a member of the Division of Medical Oncology, within the Department of Internal Medicine; directs and provides direct and indirect patient care services in both inpatient and outpatient settings; conducts ambulatory clinics; interviews, obtains and reviews medical history of patients; performs physical examinations to assess medical or surgical needs; performs relevant oncology procedures; orders special procedures, diagnostic testing, and other ancillary services; responds to consultation requests; determines, prescribes and implements treatment plans and/or medications required; documents all services and instructions provided in medical record; educates patients and promotes wellness, prevention and early detection by providing materials, resources and services to patient and their families; directs and participates in quality assessment and improvement activities; serves as preceptor and provides bedside training of residents, fellows, medical students, undergraduate & graduate students, nursing staff, and other allied medical professionals in the specialty of oncology; ensures continuing medical education requirements are met; participates in department, college, medical center and university committees and other service activities.

Department/Division Overview
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute expanded in December 2014 to become the 3rd largest cancer hospital in the U.S.  The extraordinary success of this new 398-bed state-of-the-art hospital has resulted in remarkable clinical growth and has created several opportunities for medical oncologists across the spectrum of solid tumor subspecialties. The Ohio State University is currently seeking oncology physicians at the Assistant Professor, Associate Professor and Professor rank for a variety of roles in the areas of basic and translational research, education, and inpatient and outpatient care. 

High priority searches at this time are those who desire to focus their research and patient care in GI Oncology.

OSU GI Oncology Program Features:

• 18 dedicated GI oncology focused physicians (9 medical oncologists, 5 surgical oncologists, and 4 radiation oncologists)
• Physicians are supported by team of advanced practice providers, patient navigator, social worker, onsite clinical trial coordinators, and patient experience.
• Clinics are located in stand-alone ambulatory clinic
• Translational research-oriented program with more than 25 interventional studies as well as approximately 10 non -interventional studies.  Types of studies include Phase 1 to Phase III, NCI sponsored, pharmaceutical sponsored and Investigator-initiated trials.
• Innovative therapies available for patients including first in human therapies, CAR-T cell therapy studies, and tissue banking. 
• Multi-disciplined